Dirk Thye
Board Member
Quince Therapeutics, Inc. (QNCX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
Current
-
2022-01-01–2026-09-29
-
Start not stated–2026-09-29
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Quince Therapeutics, Inc. (QNCX) | Chief Executive Officer and Chief Medical Officer | $550,000 | $2,493,625 |
| 2024 | Quince Therapeutics, Inc. (QNCX) | Chief Executive Officer and Chief Medical Officer | $550,000 | $2,732,125 |
| 2023 | Quince Therapeutics, Inc. (QNCX) | Chief Executive Officer and Chief Medical Officer | $550,000 | $1,330,500 |
| 2022 | Quince Therapeutics, Inc. (QNCX) | Chief Executive Officer and Chief Medical Officer | $316,955 | $4,968,477 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.